Hikal Company Description

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally.

It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs).

Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT.

The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients.

In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries.

The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000.

Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Hikal Limited

Country	India
Founded	1988
Industry	Pharmaceutical Preparations
Employees	2,061
CEO	Sameer Hiremath

Contact Details

Address: Great Eastern Chambers Navi Mumbai, 400614 India
Phone	91 22 6277 0299
Website	hikal.com

Stock Details

Ticker Symbol	524735
Exchange	Bombay Stock Exchange
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2834

Key Executives

Name	Position
Sameer Hiremath	Chief Executive Officer
Kuldeep Jain	Chief Financial Officer